#european-medicines-agency

[ follow ]

Hair loss drug probed in Europe over link to suicidal thoughts

The European Medicines Agency is reviewing finasteride for links to suicidal thoughts and behaviors, amid concerns over psychiatric side effects.
#lecanemab

A scientific rebellion to get Europe to approve a controversial Alzheimer's drug

Lecanemab represents a breakthrough for Alzheimer's treatment but faces significant controversy regarding its efficacy, safety, and accessibility.

Europe sidelines Alzheimer's drug: lessons must be learnt

The EMA's cautious approach may deny patients access to effective Alzheimer's treatment, contrasting with global acceptances of lecanemab.

EU regulator rejects Alzheimer's drug lecanemab

The European Medicines Agency (EMA) rejected a license for an Alzheimer's treatment due to serious side effects outweighing benefits.

A scientific rebellion to get Europe to approve a controversial Alzheimer's drug

Lecanemab represents a breakthrough for Alzheimer's treatment but faces significant controversy regarding its efficacy, safety, and accessibility.

Europe sidelines Alzheimer's drug: lessons must be learnt

The EMA's cautious approach may deny patients access to effective Alzheimer's treatment, contrasting with global acceptances of lecanemab.

EU regulator rejects Alzheimer's drug lecanemab

The European Medicines Agency (EMA) rejected a license for an Alzheimer's treatment due to serious side effects outweighing benefits.
morelecanemab
#information

Cancer drug leaflets for patients in Europe omit important facts

Cancer drug information leaflets for patients in Europe frequently omit important facts, while some are potentially misleading when it comes to treatment benefits and related uncertainties, researchers have found.Cancer is the biggest killer in Europe after heart conditions, with more than 3.7m new cases and 1.9m deaths every year, according to the World Health Organization.

European drug agency opposes Amsterdam's erotic centre plans

The European drug regulator has said it strongly opposes the creation of a multistorey erotic centre near its headquarters in Amsterdam as part of city plans to relocate sex workers away from the historic red-light district.The European Medicines Agency (EMA), which moved to Amsterdam from London in 2019 after Britain voted to leave the EU, said it was very concerned about the project, fearing nuisance, drug dealing, drunkenness and disorderly behaviour.

Cancer drug leaflets for patients in Europe omit important facts

Cancer drug information leaflets for patients in Europe frequently omit important facts, while some are potentially misleading when it comes to treatment benefits and related uncertainties, researchers have found.Cancer is the biggest killer in Europe after heart conditions, with more than 3.7m new cases and 1.9m deaths every year, according to the World Health Organization.

European drug agency opposes Amsterdam's erotic centre plans

The European drug regulator has said it strongly opposes the creation of a multistorey erotic centre near its headquarters in Amsterdam as part of city plans to relocate sex workers away from the historic red-light district.The European Medicines Agency (EMA), which moved to Amsterdam from London in 2019 after Britain voted to leave the EU, said it was very concerned about the project, fearing nuisance, drug dealing, drunkenness and disorderly behaviour.
moreinformation
[ Load more ]